While this K-Ras and cancer stemness association may rekindle CaM inhibitor drug development, further dissection of the molecular mechanism is hampered by the fact that three transcribed copies of CaM genes exist (CALM1-3) in the human genome (Toutenhoofd and Strehler, 2000). This evidence concerns the gene KRAS and cancer.